Julie R. Park, MD
Specialty:
Cancer / Blood Disorders

Program Director, Hematology/Oncology Education, Seattle Children's Hospital
Associate Professor of Pediatrics, UW School of Medicine
Associate, Clinical Research Division, Fred Hutchinson Cancer Research Center
Dr. Julie R. Park joined Seattle Children's Hospital in 1996. Dr. Park is an active member of the Children's Oncology Group (COG) Consortium, coordinating Fred Hutchinson Cancer Research Center's participation in clinical trials for treatment of neuroblastoma and non-Hodgkin lymphoma, and providing leadership for development of neuroblastoma clinical research within COG. Park's primary focus has been investigating new chemotherapy combinations for the initial treatment of high-risk neuroblastoma, a rare but aggressive form of childhood cancer. She has conducted a multi-center clinical trial to determine the feasibility and toxicity of adding topotecan and cyclophosphamide to intensively dosed standard induction agents. She is collaborating to optimize the use of radiation therapy as part of treatment for neuroblastoma. Park's work has led to the development of a national randomized Phase III trial within COG for treatment of newly diagnosed high-risk neuroblastoma.
Dr. Park has steered Seattle Children's into becoming a leading participant in the Phase I Consortium of COG and the New Approaches to Neuroblastoma Therapy Consortium. She has been actively involved in the development of novel chemotherapeutic agents that may block critical tumor cell pathways necessary for tumor cell growth and survival. Her research has also focused on developing molecular approaches to optimize the effectiveness of current chemotherapy agents. She is collaborating on an investigation of a possible relationship between a patient's ability to break down chemotherapy agents and activity against their tumor or risk for development of severe side effects.
Professional history:
Board Certified: Pediatric Hematology-Oncology
Medical School: University of Vermont College of Medicine, Burlington
To schedule an interview with Dr. Park, please contact the Public Relations department.